A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

Inclusion Criteria: * Ambulatory * Willing and able to complete the daily pad use diary, American Urology Association Symptom Score (AUASS) with Bother Score, the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), and the Work Productivity and Activity Impairment Questionnaire (WPAI) * Has not used any medication for over-active bladder symptoms for at least 14 days prior to enrollment * Diagnosed with prostate cancer, treated by Robotic Assisted Radical Prostatectomy, is voiding spontaneously and has urinary incontinence one week after removal of the indwelling catheter which requires management with 2 to 10 pads inclusive per day (24 hour days) for 7 consecutive days Exclusion Criteria: * Evidence of severe neurologic damage post-prostatectomy * Evidence of chronic urologic inflammation such as interstitial cystitis and bladder stone; uncontrolled narrow angle glaucoma; urinary or gastric retention or neurogenic bladder * Symptomatic for urinary tract infection or has a urine culture result which requires treatment as determined by the investigator. * Clinically significant history of hepatic or renal impairment (2 X Upper Limit of Normal (ULN) values in alanine aminotransferase (ALT), aspartate aminotransferase (AST) or creatinine clearance \< 30 ml/min) * History of diagnosed gastrointestinal obstruction disease * Any prior history of local radiation therapy to the prostate or rectum or any prior hormonal therapy or has planned such therap…